Acute endophthalmitis following intravitreal triamcinolone acetonide injection.
about
Emerging drugs for uveitisThe combination of intravitreal triamcinolone and phacoemulsification surgery in patients with diabeticfoveal oedema and cataract.Update on corticosteroids for diabetic macular edemaRetinitis pigmentosa-associated cystoid macular oedema: pathogenesis and avenues of interventionClinical trials on corticosteroids for diabetic macular edemaFuture pharmacological treatment options for nonexudative and exudative age-related macular degeneration.Intravitreal triamcinolone for diffuse diabetic macular oedema.Endophthalmitis with retinal necrosis following intravitreal triamcinolone acetonide injection.A review of drug options in age-related macular degeneration therapy and potential new agents.Laser photocoagulation combined with intravitreal triamcinolone acetonide injection in proliferative diabetic retinopathy with macular edema.Pharmacotherapies for diabetic retinopathy: present and future.Emerging pharmacotherapies for diabetic macular edema.Posterior subtenon triamcinolone, intravitreal triamcinolone and grid laser photocoagulation for the treatment of macular edema in branch retinal vein occlusion.Intravitreal vs. subtenon triamcinolone acetonide for the treatment of diabetic cystoid macular edema.Comparison of combination posterior sub-tenon triamcinolone and modified grid laser treatment with intravitreal triamcinolone treatment in patients with diffuse diabetic macular edema.Comparison of photocoagulation with combined intravitreal triamcinolone for diabetic macular edema.Laser photocoagulation versus combined laser photocoagulation and posterior sub-Tenon's triamcinolone injection for the primary treatment of diffuse diabetic macular edema.Endophthalmitis: Pathogenesis, clinical presentation, management, and perspectivesIntravitreal versus sub-tenon posterior triamcinolone injection in bilateral diffuse diabetic macular edema.Comparison of vitrectomized with nonvitrectomized eyes after subtenon injection of triamcinolone acetonide to treat diabetic macular edema: Retrospective comparative Analysis of an interventional case series.Viral retinitis after intravitreal triamcinolone injection in patients with predisposing medical comorbiditiesSubtenon Vs Intravitreal Triamcinolone injection in Diabetic Macular Edema, A prospective study in Chinese populationIntravitreal versus posterior subtenon injection of triamcinolone acetonide for diabetic macular edema.Neodymium: yttrium-aluminum-garnet laser anterior hyaloidotomy to treat trapped triamcinolone acetonide behind the crystalline lens after intravitreal injectionComparison of intravitreal bevacizumab, intravitreal triamcinolone acetonide, and macular grid augmentation in refractory diffuse diabetic macular edema: A prospective, randomized study.Ligand-functionalized nanoparticles target endothelial cells in retinal capillaries after systemic application.Endophthalmitis: state of the art.Comparison of the short-term effects of intravitreal triamcinolone acetonide and bevacizumab injection for diabetic macular edema.Steroid differentiation: the safety profile of various steroids on retinal cells in vitro and their implications for clinical use (an American Ophthalmological Society thesis).Presumed necrotizing viral retinitis after intravitreal triamcinolone injection: case report.Photographic estimation of the duration of high dose intravitreal triamcinolone in the vitrectomised eyePredictive factors for short-term visual outcome after intravitreal triamcinolone acetonide injection for diabetic macular oedema: an optical coherence tomography studyPhacoemulsification and intraocular lens implantation after inadvertent intracapsular injection of intravitreal dexamethasone implantThe Association between Intravitreal Steroids and Post-Injection Endophthalmitis Rates.Glucocorticoid regulation of endothelial cell tight junction gene expression: novel treatments for diabetic retinopathy.National survey of the technique of intravitreal triamcinolone injection in the United Kingdom.The pros and cons of intravitreal triamcinolone injections for uveitis and inflammatory cystoid macular edema.Ocular morbidity associated with intravitreal triamcinolone acetonide.Intravitreal triamcinolone acetonide: a change in a paradigm.Effect of Posterior Subtenon Triamcinolone Acetonide Injection on Diabetic Macular Edema Refractory to Intravitreal Bevacizumab Injection.
P2860
Q24630848-9A4E8742-E892-4912-919B-3E83EC8A3209Q24810825-9746F67D-8739-4B84-8551-F3D9332BCEF9Q28074846-129C2F5F-7CA9-4A82-BDD3-9268E848CAC4Q28076321-EDA5C8F7-81B0-4CF3-BE8B-C32C3815185AQ31146864-7D79595E-3427-4D04-84CD-ED433F27A0F6Q33212693-D4FA6E73-E13C-439A-83B3-6C5E4BCB336DQ33219578-64DB27C3-E261-4FFB-8A3B-6A34FED0BEE9Q33234405-454B7C38-EFD7-4209-BCC2-863651DDA87AQ33263803-B107F55F-463A-45C9-A37F-351F03F6FF70Q33282848-93FF8F8B-45AA-438C-A6AE-21FDF9C724E2Q33294882-CEA18426-E822-44B5-9EC8-59060D929DC2Q33304852-78C80B37-8D6E-46C8-AEFD-1A127EA91C08Q33306357-3C26DC52-19D0-44B3-BA12-E96BF08234B4Q33325652-2C019F92-EA56-41EA-A3C7-4DD4FA83CBF6Q33395775-F7BB26BB-4098-4F27-8A89-4A152D62515CQ33507910-4F9D3CA6-C410-4AB1-930B-DEB3CBBA0640Q33530909-E8D3D338-6B8E-4ABE-850A-4443C2E84E23Q33774225-52DE1449-B585-4976-BD1E-4CBB1E18C9C1Q33841803-7247D383-2C5D-4745-9B3B-246AF7DB1902Q33900514-1BAA3663-4D6B-4C10-A715-2DE49EE2D738Q34000099-D633ED68-275D-466D-A381-B749C24759B1Q34001902-3D14CB9B-BAAD-45E3-B66C-CBDDC06CF79CQ34015028-E4FBE1E4-B132-4BC1-9CFA-2B89C0441656Q34161986-D7B0CB94-CBDA-4B27-ABD8-E86D970FE96BQ34601246-A7248147-FD24-408E-B584-CF857E4E28C3Q34636224-A5803785-3CA2-4A3F-A365-F4AAC27DF997Q34952098-D97E9EFE-A9FF-4656-8057-D16543BF886AQ35009731-61B7EB6C-3761-41E2-901C-DDA57D565BCAQ35030923-B4FDA31E-EFD7-4FB9-AEB6-56EEE395E001Q35572155-69AD3D6F-9B21-49FD-B18D-F06A0E5CA71DQ35769376-2845A6C0-C9FE-40A2-80A9-566A18F4D37EQ35956280-B2C96365-32F0-4976-B2B5-81960673CE94Q35980294-0B4BCEC0-DDB8-4EA3-8390-CB656D98EA92Q36217662-27EE5182-2052-4118-9269-8D34F7290F06Q36311041-21E455E9-696D-43CA-8C51-784886478F1FQ36378901-4F241EB4-2CEC-45DD-B1B4-E151A6D30A84Q36441711-2C4B131E-8D8B-4B47-98AE-BC2BE3054D60Q36482537-3E48D4C7-DECE-40E8-8363-A2205FF9A8A8Q36500994-88681463-8442-45F9-A0DD-1221E838CF02Q36548120-718701E2-EF4F-4103-B1D7-72285BCC1645
P2860
Acute endophthalmitis following intravitreal triamcinolone acetonide injection.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Acute endophthalmitis following intravitreal triamcinolone acetonide injection.
@en
type
label
Acute endophthalmitis following intravitreal triamcinolone acetonide injection.
@en
prefLabel
Acute endophthalmitis following intravitreal triamcinolone acetonide injection.
@en
P2093
P1476
Acute endophthalmitis following intravitreal triamcinolone acetonide injection.
@en
P2093
Hugo Quiroz-Mercado
Ingrid U Scott
Jonathan Belmont
Jonathan E Sears
Juan P Sinesterra
Matthew Benz
Paul M Beer
Peter K Kaiser
Raj K Maturi
Richard S Kaiser
P304
P356
10.1016/S0002-9394(03)00483-5
P407
P577
2003-11-01T00:00:00Z